Peli BioThermal has opened its first network station in China as it looks to provide more convenient temperature-controlled logistics solutions to the broader Asia-Pacific region.

The new network station is located in Shanghai and will serve customers of the Crēdo™ on Demand rental programme.

“China is the second largest pharmaceutical market in the world, and the country has plans to significantly grow its pharmaceutical industry over the next five years,” said Dominic Hyde, vice president for global services at Peli BioThermal.

Also read: Pelican Bio adds new module to ‘School of Cool’ platform

According to the International Trade Administration, China’s pharmaceutical market value reached almost $134 billion in 2018 and is expected to grow to $161.8 billion by 2023.

The Shanghai market is home to several of China’s top 10 pharmaceutical manufacturers, including Shanghai Pharmaceuticals and Shanghai Fosun Pharmaceutical. It is also a regional a base for multinational pharma companies including Johnson & Johnson, Roche, Novartis, Pfizer, Bayer, AstraZeneca and GlaxoSmithKline.

Shanghai joins Peli BioThermal’s network of more than 100 network stations and drop points around the world. The Chinese station is the fourth network station in the Asia-Pacific region.